Tag Archives: GPS

Top 10 Undervalued Stocks For 2018

If youre looking for an undervalued company in the auto segment thats almost guaranteed to grow slow and steady over the long term, then the Lear Corporation (LEA) should definitely be on your vetting list. The lowly PE ratio of 10 is merely the bitter aftertaste of investors in a company that went belly up during the great recession because of its debt pile. I believe the company has shaken off its old habits and is fiscally more responsible now. Moreover, it holds a large market share of the seat segment and a growing one in e-systems, the second of which addresses a growing auto electrification market. So lets look at how you, as an investor, can take advantage of the troubles this company has gone through and, more importantly, come out of.

The auto industry is on the verge of the greatest disruption of our times as automaker after automaker pursues technologies like autonomous vehicle technology, electrification and connectivity. Sure, you can take the driver out of the car, but you cant take away the seats! And thats where the Lear Corporation makes its plush entrance. With 2017 seat assembly sales of $15.9 billion representing nearly a fourth of the addressable market, Lear looms large in a relatively stable and growing niche of a highly disruptive segment.

Top 10 Undervalued Stocks For 2018: Tableau Software, Inc.(DATA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

Top 10 Undervalued Stocks For 2018: Viacom Inc.(VIA)

Advisors’ Opinion:

  • [By Keith Noonan]

    While 2016 played host to a range of films that underperformed, the biggest flops belonged to Disney (NYSE:DIS), Viacom (NASDAQ:VIA) (NASDAQ:VIAB) and Lions Gate Entertainment (NYSE:LGF.A). Click through the presentation below to get the details on the year’s five biggest film flops and to learn what last year’s movie misfires mean for the companies involved.

  • [By Douglas A. McIntyre]

    The Pillsbury Doughboy is the mascot of the Pillsbury Company, which is owned by General Mills (NYSE: GIS) and J.M. Smucker (NYSE: SJM). The Doughboy was created by Pillsburys advertising agency almost 50 years ago. Pikachu are characters owned by The Pokemon Company International and appear in card games, video games, TV shows, movies and comic books. Founded in 1998, the Japanese company has achieved total games sales of almost 280 million. SpongeBob SquarePants was created for Nickelodeon, which is owned by Viacom (NASDAQ: VIA). The show premiered in 1999 and has spawned movies, video games and theme park rides. Ronald McDonald is a c

Top 10 Undervalued Stocks For 2018: Lincoln National Corporation(LNC)

Advisors’ Opinion:

  • [By Lee Jackson]

    Lincoln National Corp. (NYSE: LNC) also had the man at the top selling stock last week. Dennis Glass, the CEO of this insurance and retirement focused company, sold a block of 75,000 shares at between $71.00 and $71.28 apiece. The total for the sale was posted at $5 million. Shares closed Friday at $71.69, in a 52-week rangeof $34.16 to $73.71. The consensus price target is $73.17.

  • [By WWW.THESTREET.COM]

    * The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward).
    * Gold +$5/oz.
    * Crude oil +$0.50 and the rise is taking up some energy stocks.
    * The Russell returned to the spotlight.
    * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift.
    * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) .
    * Ag equipment–after an analyst upgrade yesterday.
    * Brokerages.
    * Homebuilders catch a bid.
    * Day one of the Masters Golf Tournament.

Top 10 Undervalued Stocks For 2018: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

Top 10 Undervalued Stocks For 2018: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.

Top 10 Undervalued Stocks For 2018: Meredith Corporation(MDP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Meredith Corporation (NYSE: MDP), a company that owns multiple TV stations, digital and mobile operations and other media platforms, agreed to acquire Time Inc (NYSE: TIME), the content company best known for operating People, Time, Fortune, and Sports Illustrated magazines.

  • [By Nelson Hem]

    See what Barron's feels the prospects are for Energy Transfer Partners LP (NYSE: ETP) if it cuts its distribution and dumps its general partner, and salesforce.com, inc. (NYSE: CRM) with its generous potential upside. Also whether regional banks like Zions Bancorp (NASDAQ: ZION) could see a boost from a proposed regulatory change, and the sweetheart deal the Koch brothers got with Meredith Corporation (NYSE: MDP).

  • [By Lisa Levin]

    Meredith Corporation (NYSE: MDP), a company that owns multiple TV stations, digital and mobile operations and other media platforms, agreed to acquire Time Inc (NYSE: TIME), the content company best known for operating People, Time, Fortune, and Sports Illustrated magazines.

  • [By Douglas A. McIntyre]

    Meredith Corp. (NYSE: MDP), the publishing, database and television station owner, has been described in several media reports as the most likely buyer of Time Inc. (NYSE: TIME). However, there are reports that the talks have stalled over valuation, which many experts believe will need to be above $20 a share to get the approval of Time’s board.

Top 10 Undervalued Stocks For 2018: Gap, Inc. (The)(GPS)

Advisors’ Opinion:

  • [By Peter Graham]

    Mid cap clothing retailer stockThe Gap Incs (NYSE: GPS)reported Q1 earnings after the market closed Thursday with shares up in premarket trading Old Navy, the company’s biggest brand by revenue,posted its fifth consecutive year of sales growth in 2016. Net sales were flat year over year at$3.4 billion (the translation of foreign currencies into U.S. dollars negatively impacted net sales by about $11 million). Gap Incs comparable sales were up 2% versus a 5% decrease last year with Old Navy Globals comparable salesup 8% versus negative 6% last year; Gap Globals comparable saleswere down4% versus negative 3%last year; and Banana Republic Globals comparable saleswere down4% versus negative 11% last year. Net income was $143 million versus net income of$127 million.

  • [By WWW.THESTREET.COM]

    * The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward).
    * Gold +$5/oz.
    * Crude oil +$0.50 and the rise is taking up some energy stocks.
    * The Russell returned to the spotlight.
    * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift.
    * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) .
    * Ag equipment–after an analyst upgrade yesterday.
    * Brokerages.
    * Homebuilders catch a bid.
    * Day one of the Masters Golf Tournament.

  • [By Peter Graham]

    A long term performance chart shows shares of athletic apparel or yoga space playersLululemon Athletica, Under Armour Inc (NYSE: UA) and The Gap Inc (NYSE: GPS) now underperforming while Nike Inc (NYSE: NKE) peaked in late 2015 with a slight downtrend since then:

Top 10 Undervalued Stocks For 2018: Sally Beauty Holdings, Inc.(SBH)

Advisors’ Opinion:

  • [By Paul Ausick]

    Sally Beauty Holdings Inc. (NYSE: SBH) posted a new 52-week low of $20.22 on Friday, down 0.3% compared with Thursday’s closing price of $20.28. The stock’s 52-week high is $32.93. Volume was more than triple the daily average of around 2 million shares. The company had no specific news Friday.

Top 10 Undervalued Stocks For 2018: The NeutriSci International (NU)

Advisors’ Opinion:

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Matthew Briar]

    Indeed, it’s also garnered interest from business partners. In November, Lexaria Bioscience and NeutriSci International Inc (CVE:NU) jointly announced they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line. In January, the duo announced it had finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.

    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

Top 10 Undervalued Stocks For 2018: Triple-S Management Corporation(GTS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap Triple-S Management Corp (NYSE: GTS) is an independent licensee of the Blue Cross Blue Shield Association. It is one of the leading players in the managed care industry in Puerto Rico. Triple-S Management has the exclusive right to use the Blue Cross Blue Shield name and mark throughout Puerto Rico, the U.S. Virgin Islands, and Costa Rica. With more than 50 years of experience in the industry, Triple-S Management offers a broad portfolio of managed care and related products in the Commercial, Medicare Advantage, and Medicaid markets under the Blue Cross Blue Shield marks. It also provides non-Blue Cross Blue Shield branded life and property and casualty insurance in Puerto Rico.

Why Investors Shouldn’t Bet on Lululemon Athletica Inc. Stock

Since mid-October, Lululemon Athletica inc. (NASDAQ:LULU) has pulled off an impressive rally. A key has been a standout earnings report, which saw a beat on the top and bottom lines. Yet it is still important to note that the year has still been fairly choppy, with the overall return for LULU stock at about 21%.

So what’s next? What should investors do with LULU stock? Well, I think the best approach is to be cautious. While the company has been able to get some of its momentum back, there are still some nagging issues.

Let’s first look at some of the pros on LULU stock. First of all, the company certainly has a powerful brand, which has been able to command premium pricing. Lululemon also has a loyal customer base.

As for the financials, they are solid. There is $650 million in the bank and no long-term debt. And here are some other metrics from the latest earnings report:

– Total comparable sales rose by 8%.

– The direct to consumer segment jumped by 26% (showing that the company is getting traction with its online efforts).

– Gross profit increased 16% to $322 million.

– Growth in Asia spiked by nearly 100%, with a 450%+ gain in China.

– The company reconfirmed its goal of achieving $4 billion in revenues by 2020.

So yes, things have been going quite well.

LULU Stock and Competitive Pressures

LULU has been able to manage the competitive threats. But this can only last so long. LULU has to fight tough rivals like Nike Inc (NYSE:NKE), adidas AG (ADR) (OTCMKTS:ADDYY), Gap Inc (NYSE:GPS) and Under Armour Inc (NYSE:UAA).

There are also scrappy startups that have access to large amounts of venture capital, like Kate Hudson’s Fabletics. Oh, and yes, there is buzz that the mighty Amazon.com, Inc. (NASDAQ:AMZN) will make a play for the market.

Actually, there are already signs that the competitive pressures are having an impact. For example, Canaccord analyst Camilo Lyon believes that the recent warehouse sales point to some ominous problems.

In a recent note, he stated: “This increase in frequency of warehouse sales could be in response to slowing brand momentum amidst rising competitive pressure and shifting fashion trends.”

Interestingly enough, his research indicates there is a growing trend toward denim, which is likely to weigh on the company. What’s more, his survey found that 18% of customers plan on buying fewer LULU pants in the coming year

Keep in mind that Lyon has a $45 price target on LULU stock.

Bottom Line on LULU Stock

If you take a look at the chart of LULU stock, it is kind of remarkable. For the most part, there has been a cap at about $80 per share, after which there is usually a notable drop. This has happened twice in 2012, twice in 2013, and once in 2016!

Then again, the fact is that Lululemon has a long history of inconsistent performance, such as with inventory issues. Let’s face it, this is common for any innovative brand.

Will things be different this time around? I would not bet on it. After all, the LULU stock price is already baking in much of the good fundamentals and then some. Note that the price to earnings multiple is at an expensive 39X, but the annualized growth rate for revenues is only about 13%. In other words, it would not be surprising to see yet another pullback.

Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities.

Compare Brokers

Top 10 Casino Stocks To Watch Right Now

“Formula for success: rise early, work hard, strike oil” – J. Paul Getty

I must confess to feeling kind of lonely at times this year being one of a handful of observers of the casino space, (and at times, the only one,) standing firm on my undiminished faith that Las Vegas Sands (NYSE:LVS) valuations were dead wrong. Now, after the Macau Parisian has opened and LVS Q3 results knocked it out of the park I suddenly have lots of company. I’m bemused to see the bandwagon suddenly getting rather crowded.

There’s no room for gloat or vapid vainglory in my gene pool. I’ve had my share of missed calls – but the casino space is my home stamping grounds. But it is fair to point out that many prophets of doom since the 2015 junket crackdown ran for the exits or pooh-poohed my consistent call on SA that LVS was still worth $70 in my view. Others agreed with me but were less bullish on price. We’re not there yet to be certain. But as I have written before, if the trade holds steady at $60 or above, I feel the ramp-up to $70 or possibly higher by Q2 2017 will move into the speed lane.

Top 10 Casino Stocks To Watch Right Now: StarTek, Inc.(SRT)

Advisors’ Opinion:

  • [By Jim Robertson]

    Just before Thanksgiving, our Under the Radar Moversnewsletter suggested shortingsmall cap business process outsourcing (BPO) stock StarTek, Inc (NYSE: SRT):

Top 10 Casino Stocks To Watch Right Now: Diplomat Pharmacy, Inc.(DPLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Diplomat Pharmacy Inc (NYSE: DPLO) were down 23 percent to $14.71. Diplomat Pharmacy agreed to buy LDI Integrated Pharmacy Services. Baird downgraded Diplomat Pharmacy from Outperform to Neutral.

  • [By Paul Ausick]

    Diplomat Pharmacy Inc. (NYSE: DPLO) dropped 7.4% Monday, posting a new 52-week low of $12.25 after closing at $13.23 on Friday. The stock’s 52-week high is $38.94. The specialty pharmacy company said this morning that revenues and adjusted EBITDA for 2016 will come in at or near the low end of the company’s previously announced range.

Top 10 Casino Stocks To Watch Right Now: Logitech International S.A.(LOGI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Mad Catz Interactive, Inc. (USA) (NYSE: MCZ) shares were also up, gaining 35 percent to $0.260 as the company disclosed that it has sold its Saitek simulation product line to Logitech International SA (USA) (NASDAQ: LOGI) for $13 million in cash.

  • [By WWW.THESTREET.COM]

    For his “Executive Decision” segment, Cramer once again sat down with Bracken Darrell, president and CEO of Logitech (LOGI) , the computer accessory maker with shares that are up 27% since Cramer last checked in back in November.

Top 10 Casino Stocks To Watch Right Now: Impax Laboratories, Inc.(IPXL)

Advisors’ Opinion:

  • [By Keith Speights]

    Impax Laboratories (NASDAQ: IPXL  ) could be watching more closely than Sanofi. The two companies reached a deal last year that allows Impax to begin marketing a generic version of Renvela in 2014. If approved, Zerenex could take away some of the profits that Impax expected to gain.

  • [By Lisa Levin]

    Shares of Impax Laboratories Inc (NASDAQ: IPXL) were down around 29 percent to $10.12. Impax Labs reported Q4 adjusted earnings of $0.16 per share on revenue of $198.4 million.

Top 10 Casino Stocks To Watch Right Now: Dominion Resources, Inc.(D)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Iron Mountain has gained 2.6% to $26.55 at 3:05 p.m., making it the fourth-best performer in the S&P 500, ahead of WPX Energy (WPX), which has gained 2.4% to $19.94, Pinnacle West Capital (PNW), which has gained 2.3% to $53.55 and Dominion Resources (D), which has risen 2.1% to $59.85.

  • [By Lisa Levin]

    Tuesday afternoon, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from National Grid plc (ADR) (NYSE: NGG) and Dominion Resources, Inc. (NYSE: D).

  • [By Justin Loiseau]

    Dominion (NYSE: D  ) added its name to the short list of U.S. companies approved to export LNG to non-Free Trade Agreement countries around the world. Its $3.6 billion Cove Point plant in Maryland will flip the facility’s focus on its head from imports from across the globe, to exports to India and Japan.

  • [By Jim Jubak, Senior Markets Editor, MoneyShow.com]

    A big part of that is Wednesday’s news that the US Department of Energy had approved a permit for Dominion Resources (D) to export liquefied natural gas from an existing liquefied natural gas import terminal in Maryland.

  • [By David Dittman]

    But power generators across the country, including Dominion Resources Inc (NYSE: D) in Virginia and Southern Company (NYSE: SO) in the Southeast, are taking significant steps to boost their solar capacity.

Top 10 Casino Stocks To Watch Right Now: Gladstone Land Corporation(LAND)

Advisors’ Opinion:

  • [By Cameron Swinehart]

    Gladstone Land Corp (LAND) –

    A U.S. based farmland investment company that currently offers a plus 9% annual distribution. It owns and leases farmland in Florida, California, Michigan and Oregon with appraised land value of $79 million. The distribution is paid monthly which should attract income investors.

Top 10 Casino Stocks To Watch Right Now: Gap, Inc. (The)(GPS)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    As tech falls, the once-forsaken shares of Gap Inc (NYSE: GPS), Macy’s Inc (NYSE: M), L Brands Inc (NYSE: LB), Costco Wholesale Corporation (NASDAQ: COST) and AT&T Inc. (NYSE: T) are surging.

  • [By WWW.THESTREET.COM]

    In retail earnings, Gap (GPS) reported in-line profit and a drop in revenue over its third quarter. Quarterly earnings declined nearly 18%, while sales dropped for their seventh straight quarter. 

  • [By Douglas A. McIntyre]

    One of the notable things about the mall is the number of troubled retailers it houses. Long term, this may be bad for the mall’s finances. Macy’s, Abercrombie & Fitch Co. (NYSE: ANF), GameStop Corp. (NYSE: GME) and Gap Inc. (NYSE: GPS) have locations. However, Mall of America has buttressed its tenant list with scores of restaurants and with retailers like Apple Inc. (NASDAQ: AAPL), Microsoft Corp. (NASDAQ: MSFT) and T-Mobile US Inc. (NASDAQ: TMUS), which have very well-financed parents.

  • [By Douglas A. McIntyre]

    Retailer shares have been unable to fully stabilize after sell-offs that accompanied their earnings for the 2016 holiday period. Some retailers shuttered stores. Others gave pessimistic guidance. The slide began in earnest again, as retail stocks got punished on Monday. Kohl’s Corp. (NYSE: KSS), Macy’s Inc. (NYSE: M), Gap Inc. (NYSE: GPS) and Nordstrom Inc. (NYSE: JWM) were among the largest losers in the S&P 500.

  • [By Nicholas Rossolillo]

    However, the ongoing closures could help remaining shopping mall businesses like The Gap (NYSE:GPS)and American Eagle Outfitters (NYSE:AEO). Neither company has been immune to the changing times and both have closed down stores of their own. However, some of these clothiers — American Eagle, in particular — have managed to hang on to old clientele and expand into new markets.

  • [By Peter Graham]

    A long term performance chart shows Abercrombie & Fitch Cobouncing lower since 2013while small capUrban Outfitters, Inc (NASDAQ: URBN)andmid capThe Gap Inc (NYSE: GPS) began bouncing lower a bit later in 2015:

Top 10 Casino Stocks To Watch Right Now: Occidental Petroleum Corporation(OXY)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Chris Lange]

    Occidental Petroleum Corp.s (NYSE: OXY) short interest increased to 17.60 million shares from the previous reading of 15.53 million. Shares closed most recently at $66.90, in a 52-week range of $58.24 to $78.48.

  • [By Chris Lange]

    Occidental Petroleum Corp.s (NYSE: OXY) short interest increased to 16.11 million shares from the previous reading of 15.70 million. Shares were recently at $62.83, in a 52-week range of $61.01 to $78.48.

  • [By Michael Flannelly]

    Early on Monday, analysts at Deutsche Bank lowered their price target on Occidental Petroleum Corporation (OXY) to reflect a lower-than-expected valuation of an asset that the oil and gas exploration company is trying to sell.

    Though the analysts lowered OXY’s price target from $114 to $109, they still maintain a “Buy” rating on the stock. The new price target suggests a 22% upside to the stock’s Friday closing price of $89.49.

    Deutsche Bank analyst Paul Sankey said, “Bloomberg Finance LP reports that Oxy is seeking sale of 40% of Mideast operations for around $8bn, which would imply $20bn total value for the unit. However reportedly some suitors are valuing the asset at around $15bn. This is a relatively negative valuation against our previous view that Oxy would be seeking $25+bn for its MENA business. We are cutting our price target to $109/share to reflect this lower implied valuation.”

    Occidental Petroleum shares were up 96 cents, or 1.07%, during pre-market trading on Monday. The stock is up 16.81% year-to-date.

Top 10 Casino Stocks To Watch Right Now: PetMed Express, Inc.(PETS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Monday afternoon, the non-cyclical consumer goods & services shares surged 0.22 percent. Meanwhile, top gainers in the sector included Petmed Express Inc (NASDAQ: PETS), up 20 percent, and Kroger Co (NYSE: KR), up 3 percent.

  • [By Peter Graham]

    A long term performance chart shows Blue Buffalo Pet Products roughly back up to its IPO close for retail investors while fresh pet food peer Freshpet Inc (NASDAQ: FRPT) isstill below IPO levels and pet stocksCentral Garden & Pet Co (NASDAQ: CENT) andPetmed Express (NASDAQ: PETS) have been much stronger performers in the pet sector after PetSmart (NASDAQ: PETM) was acquired by a private equity group:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Peter Graham]

    Small cap pet stockPetmed Express Inc (NASDAQ: PETS) reportedQ2 earnings before the market opened this morning with shares soaring this morning as earnings were well beyond expectations. Net sales increased 10% to $66.7 million as new order sales increased 9% to $11.6 million while the Company’s online sales for the quarter ended September 30, 2017 were approximately 84% of all sales compared to 82% for the same quarter the prior year (with online sales increasing 12%). Net income was $8.8 million versusnet income of $4.9 million. The CEO commented:

Top 10 Casino Stocks To Watch Right Now: NCI Building Systems, Inc.(NCS)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, small cap NCI Building Systems (NYSE: NCS) sank 20.54% after the maker of metal products for the nonresidential building industry reported disappointing Q3 results and cut its sales outlook. NCI Building Systems is one of North America’s largest integrated manufacturers and marketers of coatings, components and metal buildings for the nonresidential building industry and is comprised of a family of companies operating manufacturing facilities across the United States, Canada, Mexico and China (with additional sales and distribution offices throughout the United States and Canada).

  • [By Monica Gerson]

    NCI Building Systems Inc (NYSE: NCS) posted upbeat results for its second quarter on Tuesday. NCI Building Systems shares rose 1.24 percent to $16.30 in the after-hours trading session.

  • [By Lisa Levin]

    NCI Building Systems Inc (NYSE: NCS) was down, falling around 14 percent to $15.27. NCI Building Systems reported Q3 adjusted earnings of $0.33 per share on revenue of $462.4 million.

  • [By Scott Rubin]

    Equity gainers on the day included Chico's FAS, Inc. (NYSE: CHS), which surged more than 12 percent on the day, and Himax Technologies (NASDAQ: HIMX), which climbed almost 9 percent in the wake of an afternoon rally. Losers included NCI Building Systems Inc. (NYSE: NCS), which fell 15 percent after earnings, and H&R Block inc (NYSE: HRB), which fell almost 11 percent on the day after its Q1 results.

  • [By Lisa Levin]

    On Thursday, the industrial sector proved to be a source of strength for the market. Leading the sector was strength from Envirostar Inc (NYSE: EVI) and NCI Building Systems Inc (NYSE: NCS).

Why Investors Shouldn’t Bet on Lululemon Athletica Inc. Stock

Since mid-October, Lululemon Athletica inc. (NASDAQ:LULU) has pulled off an impressive rally. A key has been a standout earnings report, which saw a beat on the top and bottom lines. Yet it is still important to note that the year has still been fairly choppy, with the overall return for LULU stock at about 21%.

So what’s next? What should investors do with LULU stock? Well, I think the best approach is to be cautious. While the company has been able to get some of its momentum back, there are still some nagging issues.

Let’s first look at some of the pros on LULU stock. First of all, the company certainly has a powerful brand, which has been able to command premium pricing. Lululemon also has a loyal customer base.

As for the financials, they are solid. There is $650 million in the bank and no long-term debt. And here are some other metrics from the latest earnings report:

– Total comparable sales rose by 8%.

– The direct to consumer segment jumped by 26% (showing that the company is getting traction with its online efforts).

– Gross profit increased 16% to $322 million.

– Growth in Asia spiked by nearly 100%, with a 450%+ gain in China.

– The company reconfirmed its goal of achieving $4 billion in revenues by 2020.

So yes, things have been going quite well.

LULU Stock and Competitive Pressures

LULU has been able to manage the competitive threats. But this can only last so long. LULU has to fight tough rivals like Nike Inc (NYSE:NKE), adidas AG (ADR) (OTCMKTS:ADDYY), Gap Inc (NYSE:GPS) and Under Armour Inc (NYSE:UAA).

There are also scrappy startups that have access to large amounts of venture capital, like Kate Hudson’s Fabletics. Oh, and yes, there is buzz that the mighty Amazon.com, Inc. (NASDAQ:AMZN) will make a play for the market.

Actually, there are already signs that the competitive pressures are having an impact. For example, Canaccord analyst Camilo Lyon believes that the recent warehouse sales point to some ominous problems.

In a recent note, he stated: “This increase in frequency of warehouse sales could be in response to slowing brand momentum amidst rising competitive pressure and shifting fashion trends.”

Interestingly enough, his research indicates there is a growing trend toward denim, which is likely to weigh on the company. What’s more, his survey found that 18% of customers plan on buying fewer LULU pants in the coming year

Keep in mind that Lyon has a $45 price target on LULU stock.

Bottom Line on LULU Stock

If you take a look at the chart of LULU stock, it is kind of remarkable. For the most part, there has been a cap at about $80 per share, after which there is usually a notable drop. This has happened twice in 2012, twice in 2013, and once in 2016!

Then again, the fact is that Lululemon has a long history of inconsistent performance, such as with inventory issues. Let’s face it, this is common for any innovative brand.

Will things be different this time around? I would not bet on it. After all, the LULU stock price is already baking in much of the good fundamentals and then some. Note that the price to earnings multiple is at an expensive 39X, but the annualized growth rate for revenues is only about 13%. In other words, it would not be surprising to see yet another pullback.

Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities.

Compare Brokers

Why Investors Shouldn’t Bet on Lululemon Athletica Inc. Stock

Since mid-October, Lululemon Athletica inc. (NASDAQ:LULU) has pulled off an impressive rally. A key has been a standout earnings report, which saw a beat on the top and bottom lines. Yet it is still important to note that the year has still been fairly choppy, with the overall return for LULU stock at about 21%.

So what’s next? What should investors do with LULU stock? Well, I think the best approach is to be cautious. While the company has been able to get some of its momentum back, there are still some nagging issues.

Let’s first look at some of the pros on LULU stock. First of all, the company certainly has a powerful brand, which has been able to command premium pricing. Lululemon also has a loyal customer base.

As for the financials, they are solid. There is $650 million in the bank and no long-term debt. And here are some other metrics from the latest earnings report:

– Total comparable sales rose by 8%.

– The direct to consumer segment jumped by 26% (showing that the company is getting traction with its online efforts).

– Gross profit increased 16% to $322 million.

– Growth in Asia spiked by nearly 100%, with a 450%+ gain in China.

– The company reconfirmed its goal of achieving $4 billion in revenues by 2020.

So yes, things have been going quite well.

LULU Stock and Competitive Pressures

LULU has been able to manage the competitive threats. But this can only last so long. LULU has to fight tough rivals like Nike Inc (NYSE:NKE), adidas AG (ADR) (OTCMKTS:ADDYY), Gap Inc (NYSE:GPS) and Under Armour Inc (NYSE:UAA).

There are also scrappy startups that have access to large amounts of venture capital, like Kate Hudson’s Fabletics. Oh, and yes, there is buzz that the mighty Amazon.com, Inc. (NASDAQ:AMZN) will make a play for the market.

Actually, there are already signs that the competitive pressures are having an impact. For example, Canaccord analyst Camilo Lyon believes that the recent warehouse sales point to some ominous problems.

In a recent note, he stated: “This increase in frequency of warehouse sales could be in response to slowing brand momentum amidst rising competitive pressure and shifting fashion trends.”

Interestingly enough, his research indicates there is a growing trend toward denim, which is likely to weigh on the company. What’s more, his survey found that 18% of customers plan on buying fewer LULU pants in the coming year

Keep in mind that Lyon has a $45 price target on LULU stock.

Bottom Line on LULU Stock

If you take a look at the chart of LULU stock, it is kind of remarkable. For the most part, there has been a cap at about $80 per share, after which there is usually a notable drop. This has happened twice in 2012, twice in 2013, and once in 2016!

Then again, the fact is that Lululemon has a long history of inconsistent performance, such as with inventory issues. Let’s face it, this is common for any innovative brand.

Will things be different this time around? I would not bet on it. After all, the LULU stock price is already baking in much of the good fundamentals and then some. Note that the price to earnings multiple is at an expensive 39X, but the annualized growth rate for revenues is only about 13%. In other words, it would not be surprising to see yet another pullback.

Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities.

Compare Brokers